TY - JOUR
KW - Adult
KW - Buprenorphine/therapeutic use
KW - COVID-19
KW - Hospitals, Public
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - New York City/epidemiology
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pandemics
KW - Retrospective Studies
KW - SARS-CoV-2
KW - Telemedicine
AU - B. Tofighi
AU - J. McNeely
AU - D. Walzer
AU - K. Fansiwala
AU - A. Demner
AU - C. S. Chaudhury
AU - I. Subudhi
AU - D. Schatz
AU - T. Reed
AU - N. Krawczyk
A1 - 
AD - Department of Population Health, New York University School of Medicine, New York, NY (BT, JM, DW, KF, CSC, IS, DS, NK); Division of General Internal Medicine, Bellevue Hospital Center, New York, NY (BT, JM, DS); Center for Drug Use and HIV Research, New York, NY (BT, JM, NK); NYC Health+Hospitals, New York, NY (DS); Department of Psychiatry, New York University School of Medicine, New York, NY (AD); Department of Psychiatry, Bellevue Hospital Center, New York, NY (DW, KF, AD, CSC, IS, TR).
BT - Journal of addiction medicine
C5 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
CP - 1
DO - 10.1097/ADM.0000000000000809
IS - 1
JF - Journal of addiction medicine
LA - eng
M1 - Journal Article
PB - American Society of Addiction Medicine
PY - 2022
SN - 1935-3227; 1932-0620; 1932-0620
SP - e40
EP - e43
EP - 
T1 - A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic
T2 - Journal of addiction medicine
TI - A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic
U1 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
U2 - 33560696
U3 - 10.1097/ADM.0000000000000809
VL - 16
VO - 1935-3227; 1932-0620; 1932-0620
Y1 - 2022
Y2 - Jan-Feb 01
ER -